Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919900 · ClinicalTrials.gov registry record · NA
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
A NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by Georgia State University.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06919900: Recruiting NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by Georgia State University.
NCT06919900 is a NA study of Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 64 participants, below the 560-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06919900, a NA study of Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by Georgia State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this interventional study is to examine the overall motor learning capacity from exposure to repeated perturbations among ambulatory people with multiple sclerosis (MS). This project will advance our understanding of learning new motor skills from exposure to external perturbations. If it is proven that people with MS can learn motor skills from perturbation training, the findings from this study will pave a theoretical foundation for applying perturbation training as a promising fall prevention intervention for people with MS.
Primary Outcome
A loadcell will be connected to the safety harness (above the participant's head) and will measure the force exerted on the safety harness during each perturbation trial. Perturbation outcomes will be classified as falls if the peak loadcell force exceeds 30% of the body weight. Otherwise, perturbation outcomes will be classified as non-falls.
Conditions Studied
Interventions
- BEHAVIORAL Perturbation Training
- BEHAVIORAL Treadmill Walking
Study Locations (1)
Georgia
- Georgia State University Biomechanics Lab - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06919900 shows while recruiting
NCT06919900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 560-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Multiple Sclerosis (Relapsing Remitting) appearing as the primary indexed condition, and to 2 interventions - of which Perturbation Training is the first listed.
NCT06919900 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06919900 about?
NCT06919900 is a clinical study titled "Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis". The primary purpose of this interventional study is to examine the overall motor learning capacity from exposure to repeated perturbations among ambulatory people with multiple sclerosis (MS). This project will advance our understanding of learning new motor skills from exposure to external perturba...
What is the current status of trial NCT06919900?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2026-01. Estimated completion is 2028-12.
What conditions does trial NCT06919900 study?
This clinical trial studies the following conditions: Multiple Sclerosis (Relapsing Remitting).
What interventions are being tested in trial NCT06919900?
The interventions under investigation include: Perturbation Training (BEHAVIORAL), Treadmill Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT06919900?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06919900 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis (Relapsing Remitting)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06919900's enrollment target sits among peer trials
64 18th of 29 higher than 12 of 29 other Multiple Sclerosis (Relapsing Remitting) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis (Relapsing Remitting) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
RECRUITING · NA
-
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
RECRUITING · NA
-
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
RECRUITING · NA
-
The Synergistic Effects of AIH and FES in Persons With MS
ACTIVE NOT RECRUITING · NA
-
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia